Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China
- PMID: 25529103
- PMCID: PMC4598328
- DOI: 10.1111/add.12836
Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China
Abstract
Background and aims: To decrease infectious disease transmission, China is expanding methadone maintenance treatment (MMT). This study evaluated the prevalence of hepatitis C virus (HCV) infection at MMT entry, seroconversion rates after admission and potential risk factors for HCV seroconversion during MMT in Wuhan, China.
Design: Cross-sectional survey of all patients entering MMT and prospective follow-up of patients HCV seronegative at admission.
Setting: All MMT clinics in Wuhan, China.
Participants: A total of 12 755 opiate-dependent individuals entering MMT between May 2006 and June 2011; 1200 participants HCV seronegative at admission were followed.
Measurements: Serological tests for HCV and self-report data on risk behaviors at MMT admission; urine toxicology results and repeated assessments of serological status and risk behaviors during treatment on patients HCV seronegative at admission.
Findings: HCV seroprevalence at admission was 72.1% [95% confidence interval (CI) = 71.3-72.9%] and 555/1200 (46.3%, 95% CI = 43.5-49.1%) patients seroconverted to HCV during MMT. The mean time to HCV seroconversion was 3 (95% CI = 2.84-3.07) years with a cumulative seroconversion rate of 34.5 (95% CI = 31.5-36.9) per 100 person-years. Significant predictors of HCV conversion included injection drug use in the past 30 days [relative hazard (RH) 2.0, 95% CI: 1.6 - 2.4, P=0.002] and the rate of opiate-positive urine tests during MMT (RH 2.0, 95% CI = 1.3-3.1, P<0.001).
Conclusions: Methadone maintenance treatment patients in Wuhan, China show a high prevalence of hepatitis C virus at admission (72.1%) and a high rate of seroconversion during treatment (46.3%). Seroconversion is associated with continuing injection drug use.
Keywords: Behavioral risks; hepatitis C virus; injection drug use; methadone maintenance treatment; opiate dependence; seroconversion.
© 2015 Society for the Study of Addiction.
Conflict of interest statement
None.
Figures


Comment in
-
Commentary on Zhou et al. (2015): Research on methadone maintenance treatment (MMT) as prevention for HCV infection--MMT is not a single variable.Addiction. 2015 May;110(5):803-4. doi: 10.1111/add.12861. Addiction. 2015. PMID: 25868543 No abstract available.
Similar articles
-
Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study.BMJ Open. 2015 Aug 21;5(8):e008162. doi: 10.1136/bmjopen-2015-008162. BMJ Open. 2015. PMID: 26297365 Free PMC article.
-
Low risk for hepatitis C seroconversion in methadone maintenance treatment.J Addict Med. 2011 Sep;5(3):214-20. doi: 10.1097/ADM.0b013e31820e13dd. J Addict Med. 2011. PMID: 21844836
-
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users.Addiction. 2014 Dec;109(12):2053-9. doi: 10.1111/add.12682. Epub 2014 Aug 14. Addiction. 2014. PMID: 25041346 Free PMC article.
-
Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.BMJ Open. 2017 Jul 13;7(7):e015524. doi: 10.1136/bmjopen-2016-015524. BMJ Open. 2017. PMID: 28710214 Free PMC article.
-
Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review.Addict Behav. 2014 Jan;39(1):22-9. doi: 10.1016/j.addbeh.2013.09.001. Epub 2013 Sep 9. Addict Behav. 2014. PMID: 24090627 Review.
Cited by
-
Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study.BMJ Open. 2015 Aug 21;5(8):e008162. doi: 10.1136/bmjopen-2015-008162. BMJ Open. 2015. PMID: 26297365 Free PMC article.
-
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2. Cochrane Database Syst Rev. 2017. PMID: 28922449 Free PMC article.
-
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis.Int J Drug Policy. 2020 Oct;84:102875. doi: 10.1016/j.drugpo.2020.102875. Epub 2020 Jul 27. Int J Drug Policy. 2020. PMID: 32731112 Free PMC article.
-
Educational and Behavioral Counseling in a Methadone Maintenance Treatment Program in China: A Randomized Controlled Trial.Front Psychiatry. 2018 Apr 4;9:113. doi: 10.3389/fpsyt.2018.00113. eCollection 2018. Front Psychiatry. 2018. PMID: 29670549 Free PMC article.
-
Evaluation of an implementation of methadone maintenance treatment in China.Drug Alcohol Depend. 2015 Dec 1;157:60-7. doi: 10.1016/j.drugalcdep.2015.10.001. Epub 2015 Oct 8. Drug Alcohol Depend. 2015. PMID: 26601934 Free PMC article.
References
-
- World Health Organization. [accessed 17 June 2014];Guidance on prevention of viral hepatitis B and C among people who inject drugs. Available at: http://apps.who.int/iris/bitstream/10665/75192/1/WHO_HIV_2012.18_eng.pdf. (Archived by WebCite® at http://www.webcitation.org/6QP7PVFIz) - PubMed
-
- Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18:362–358. - PubMed
-
- Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558–67. - PubMed
-
- Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008;122:990–1003. - PubMed
-
- Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004;33:182–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous